🇺🇸 FDA
Patent

US 7670599

YKL-40 as a marker and prognostic indicator for cancers

granted A61KA61K2039/505A61P

Quick answer

US patent 7670599 (YKL-40 as a marker and prognostic indicator for cancers) held by The Regents of the University of California expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61P, A61P19/02, A61P31/00